CAUS ETF: what CAUS.TO is, what it holds, and how it works

Short answer: CAUS.TO is the Avantis CIBC U.S. All-Cap Equity ETF. It listed on the TSX on February 20, 2026, at a 0.19% management fee. It holds the broad U.S. stock market, large through small, with deliberate tilts toward value, smaller, and profitable companies. It is the Canadian-listed sibling of the U.S.-listed AVUS. The full MER isn’t published yet because of the first-year reporting rule.

CAUS is the U.S. sleeve of the Avantis CIBC lineup. It covers the entire U.S. market in one CAD-denominated ticker, run on the Avantis factor methodology.

This is not financial advice. I’m sharing what I’ve learned from my own research, and your situation might differ. Fund details change, so always check the latest disclosures before deciding.

What CAUS actually is

CAUS.TO is an ETF listed on the TSX in Canadian dollars. CIBC handles the wrapper; Avantis Investors runs the strategy. It holds U.S. companies across the full market-cap range, weighted toward value and profitability rather than pure size. Its closest U.S.-listed cousin is AVUS, the Avantis U.S. Equity ETF.

What CAUS holds

CAUS holds a broad basket of U.S. companies from megacaps down to small-caps, screened toward value and profitability. Versus a cap-weighted S&P 500 or total-market fund, it carries less concentration in the largest technology names and more weight in cheaper, profitable companies across the size range.

CIBC hasn’t published a full top-holdings breakdown yet. The mandate is clear: broad U.S. equity, Avantis factor methodology.

The fee, and the first-year MER rule

CAUS’s management fee is 0.19%, one of the two cheapest in the Avantis CIBC lineup. The U.S.-listed AVUS runs at a 0.15% expense ratio, but buying AVUS as a Canadian means converting to U.S. dollars and running a USD account. CAUS removes that friction by being CAD-denominated. The full MER hasn’t been published yet under the first-year rule; expect it a few basis points above 0.19%.

How the factor tilt works

A cap-weighted U.S. index fund owns the market by size, so the biggest companies dominate. CAUS tilts toward value (cheaper on fundamentals), size (less megacap concentration), and profitability (reliably profitable companies favoured). The academic basis is Fama-French plus Novy-Marx on profitability.

How CAUS fits with the rest of the lineup

CAUS is the U.S. building block. It pairs with CACE (Canada), CADE (international), and CAEM (emerging markets) for a self-built Avantis portfolio, or sits as a deliberate U.S. tilt on a global core. If you want one fund and no work, CAGE already holds the U.S. internally and you don’t need CAUS separately. Full lineup in the Avantis CIBC ETFs guide.

Frequently asked questions

What is CAUS.TO?

The Avantis CIBC U.S. All-Cap Equity ETF, managed by CIBC with Avantis as sub-advisor. Listed on the TSX February 20, 2026, CAD-denominated, holding the broad U.S. market tilted toward value, smaller size, and profitability.

What is CAUS’s MER?

Management fee 0.19%. Full MER not published yet (first-year rule); expect a few basis points higher. The U.S.-listed AVUS is 0.15%, but carries currency-conversion and USD-account friction for a Canadian.

Is CAUS the Canadian version of AVUS?

It’s the closest Canadian-listed equivalent: same Avantis broad-U.S.-equity approach, CAD-denominated, no USD conversion. AVUS has a longer track record; CAUS launched in February 2026.

Can I hold CAUS in a TFSA or RRSP?

Yes, in any standard Canadian registered account or non-registered account. Because it’s Canadian-listed, there’s no currency conversion to buy it.

Bottom line

CAUS is a cheap, broad U.S.-equity sleeve with a factor tilt, in Canadian dollars. It’s a building block for a self-constructed Avantis portfolio or a U.S. tilt on a core. If you want simplicity, CAGE or a broad all-in-one already covers the U.S. without a separate holding.